ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /化合物

トリメチルアミンN-オキシド (無水)

Trimethylamine oxide

HCID 1145
ノートを作成反応を作成見積依頼を出す
印刷プレビュー
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
1184-78-7
標準SMILES
C[N+](C)(C)[O-]
InChIKey
UYPYRKYUKCHHIB-UHFFFAOYSA-N
分子式
C3H9NO
平均分子量
75.11 g/mol
単同位体質量
75.06841391

概要

Trimethylamine N-oxide is a tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine. It has a role as a metabolite, an osmolyte and an Escherichia coli metabolite. It is functionally related to a trimethylamine. It is a conjugate base of a hydroxytrimethylaminium.

名称と識別子

優先名称
Trimethylamine oxide
IUPAC
N,N-dimethylmethanamine oxide
現地名
トリメチルアミンN-オキシド (無水)
英語名
Trimethylamine N-oxide
分子式
C3H9NO
分子量
75.11

名称と別名

TRIMETHYLAMINE N-OXIDETrimethylamine oxide1184-78-7N,N-dimethylmethanamine oxideTrioxTrimethyloxamineTMAON,N-Dimethylmethanamine N-oxideMethanamine, N,N-dimethyl-, N-oxidetrimethylammonium oxide(CH3)3NOFLD0K1SJ1A
名称をさらに表示
トリメチルアミンN-オキシド (無水)トリメチルアミン N-オキシド (無水)トリメチルアミンオキシドトリメチルアミン N-オキシドトリメチルアミン-N-オキシドTrimetlylamine OxideTrimethylamine N-Oxide AnhydrousTMANO AnhydrousTRIMETHYLAMINOXIDErimethylamineN-oxide
NSC-408426CHEBI:15724FEMA NO. 4245RefChem:933449214-675-6Trimethylamine N-oxide dihydratetrimethylamine-N-oxideTrimethylamine, N-oxide

データベース識別子

CAS
1184-78-7、85408-49-7
PubChem CID
1145
DTXSID
DTXSID8049678
ChEBI
CHEBI:15724
UNII
FLD0K1SJ1A
EC Number
214-675-6、287-011-6
Nikkaji
J7.304K

物性

構造計算による物性

XLogP
-0.3
極性表面積
18.1 Ų
水素結合供与体数
0
水素結合受容体数
1
回転可能結合数
0
重原子数
5
形式電荷
0
複雑度
28.4

実験および物理化学的性質

Chemical ClassesNitrogen Compounds -> Amine Oxides
DrugsPharmaceuticals -> Metabolite of Levocarnitine
SpringerMaterials PropertiesSchoenflies notation
LogP-2.570
Food AdditivesFLAVORING AGENT OR ADJUVANT -> FDA Substance added to food
Flavoring AgentsEU Flavoring substances
Solubility · 3 件

454 mg/mL

Soluble in water

Soluble (in ethanol)

Melting Point95 - 99 °C
Physical Description · 4 件

Liquid

Colorless solid; Highly hygroscopic; [Merck Index]

Solid

Colourless to yellow solid; Odourless

物理化学的性質

融点
220 · 220-222 °C (lit.)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

Danger

H302 (71.8%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P264+P265, P270, P273, P280, P301+P317, P302+P352, P305+P354+P338, P317, P321, P330, P332+P317, P362+P364, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 188 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

H302+H332 (31.5%): Harmful if swallowed or if inhaled [Warning Acute toxicity, oral; acute toxicity, inhalation]

危険有害性情報

Regulatory Information · 5 件

Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)

Methanamine, N,N-dimethyl-, N-oxide is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Methanamine, N,N-dimethyl-, N-oxide are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 03-04-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/25104

Methanamine, N,N-dimethyl-, N-oxide: Does not have an individual approval but may be used under an appropriate group standard

Amines, C12-16-alkyldimethyl, N-oxides: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Hazards SummaryThe dihydrate is CAS# 62637-93-8; May cause skin, eye, and respiratory tract irritation; [Merck Index] Safe when used as a flavoring agent in food; [JECFA] A skin and strong eye irritant; [Sigma-Aldrich MSDS]
Hazard Classes and Categories · 2 件

Acute Tox. 4 (57.6%)

Acute Tox. 4 (71.8%)

安全と保護具

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Trimethylamine-N-oxide is biosynthesized in the liver from trimethylamine (TMA), which is derived from choline. Flavin monooxygenase 3 (FMO3) has been implicated in the oxidation of TMA since individuals with mutations in FMO3 present with accumulation of TMA levels, causing fish malodor syndrome. TMAO is secreted in the urine and is not metabolized any further.

MeSH Pharmacological ClassificationElectron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION).
Tissue LocationsEpidermis
Cellular LocationsCytoplasm

用途と製造

Uses · 2 件

Present in marine organisms; Used in organic synthesis (oxidizing agent); [Merck Index] Used to make quaternary ammonium compounds, as an insect attractant, and a warning agent for flammable gas; [ChemIDplus] Used as flavoring agent or adjuvant; [FDA]

TMAO is produced endogenously in the body. High levels are found in fish. It is a uremic toxic and an atherotoxin or atherogenic. It is also an osmolyte.

U.S. Production2020: <50,000 lb
Industry UsesNot Known or Reasonably Ascertainable
Use Classification · 2 件

Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes

Flavoring Agents -> JECFA Flavorings Index

General Manufacturing Information · 2 件

Not Known or Reasonably Ascertainable

Methanamine, N,N-dimethyl-, N-oxide: ACTIVE

関連反応

146 件
反応記録を作成
HRID 54580 の反応式
HRID 54580反応物としてuspto-grants-1997_04
HRID 66402 の反応式
HRID 66402反応物としてuspto-grants-1978_12
HRID 67014 の反応式
HRID 67014反応物としてuspto-grants-1982_08
HRID 67031 の反応式
HRID 67031反応物としてuspto-grants-1982_08
HRID 75087 の反応式
HRID 75087反応物としてuspto-grants-2014_09
HRID 76299 の反応式
HRID 76299反応物としてuspto-grants-2014_09
HRID 76300 の反応式
HRID 76300反応物としてuspto-grants-2014_09
HRID 76302 の反応式
HRID 76302反応物としてuspto-grants-2014_09
1 / 19 ページ

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
その他の操作
ノートを作成反応を作成見積依頼を出す
沸点
133.8 °C · 133.8°C (rough estimate)
比重(密度)
0.9301 · 0.9301 (rough estimate)
蒸気圧
23.5 Pa · 23.5Pa at 20℃
屈折率
1.4698 · 1.4698 (estimate)
FEMA
4245 · 4245 | TRIMETHYLAMINE OXIDE
貯蔵温度
Hygroscopic, Room Temperature, under inert atmosphere
溶解性
クロロホルム、DMSO、メタノール(微量)
酸解離定数(Pka)
4.65 · 4.65(at 25℃)
外見
個体
色
ペールイエロー
臭い (Odor)
無臭
水溶解度
793 g/L · 793g/L at 24.5℃
Merck
14 · 14,9711
JECFA Number
1614 · 1614
安定性
吸湿性
InChI
1S/C3H9NO/c1-4(2,3)5/h1-3H3
InChIKey
UYPYRKYUKCHHIB-UHFFFAOYSA-N
SMILES
C[N+](C)(C)[O-]
LogP
-2.79 · -2.79
EPAの化学物質情報
Methanamine, N,N-dimethyl-, N-oxide (1184-78-7)

化学的性質

化学的特性White crystalline powder

Minimum Risk Level>75 uM in blood

毒性情報

Treatment · 1 件

Kidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored. Treatments for atherosclerosis may include lifestyle changes (exercise, eating fruits and vegetables), medicines (statins), and medical procedures or surgery (angioplasty).

Health Effects · 1 件

High endogenous levels of TMAO in the blood (>100 uM) can lead to uremia which can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease. Chronically high levels of TMAO in the blood can also lead to the development of atherosclerosis and atherosclerotic plaques.

Exposure RoutesEndogenous, Ingestion
Toxicity Summary · 1 件

Uremic toxins such as TMAO are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (5). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (6). TMAO appears to contribute to the development of atherosclerosis in part by promoting cholesterol accumulation within macrophages, perhaps by inducing scavenger receptors such as CD36 and SRA1, both of which are involved in the uptake of modified lipoproteins (A15344).

Signs and Symptoms · 1 件

As a uremic toxin, TMAO can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present. Symptoms of atherosclerosis include angina, chest pain, breathlessness, nausea, dizziness, leg pains, weakness or numbness in the legs, erectile dysfunction, hairloss on legs or feet and leg sores that never heal.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity Data>100 uM in blood is usually indicative of uremia

安全データ

wgk
3
tsca
TSCA listed
hs_code
2904.20.5000
risk_code
36/37/38
hazard_code
Xi
safety_code
26-37/39
Hazard Classifications
Acute Tox. 4 InhalationAcute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids
応用分野 · 3 件

説明Trimethylamine N-oxide (TMAO) is a metabolite of choline, phosphatidylcholine, and L-carnitine . It is formed by gut microbiota-mediated metabolism of choline, phosphatidylcholine, and L-carnitine to TMA followed by oxidation of TMA by flavin-containing monooxygenase 3 (FMO3) in the liver. Dietary administration of TMAO (0.12% w/w) increases renal tubulointerstitial fibrosis, collagen deposition, and Smad3 phosphorylation in mice and increases aortic lesion area in atherosclerosis-prone ApoE-/- mice. Plasma levels of TMAO are elevated in patients with chronic kidney disease and decreased in patients with active, compared with inactive, ulcerative colitis. Elevated plasma levels of TMAO are associated with increased risk of cardiovascular disease.

使用TrimethylamineN-oxide can be used:As a demetallationand decarbonylationreagent for organometallic compounds.To prepare azomethine ylide by reaction with lithium di-isopropylamide. This, in turn, may be reacted with simple alkenes to obtain corresponding pyrrolidines.To mediate the conversion of thiols to disulfides.

一般的な説明TrimethylamineN-oxide is an organic compound that belongs to the class of amine oxides. It is generally found in the tissues of marine organisms, wherein it helps protect them from harsh conditions like salinity, hydrostatic pressure, temperature, and high urea.

上流・下流製品情報

上流原料

オキシドールトルエントリメチルアミン水溶液 3 0 %

下流製品

N,N'-ジメチルピペラジン2-ジメチルアミノメチルフェノール (フェノール含む)(1-メチルピロリジン-3-イル)メタノール

補足説明

定義本品は、次の化学式で表される3級アミンオキシドである。

定義ChEBI: An N-oxide derived from triethylamine.